HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY
AD Shapiroa, A Abrahamb, S Linaric, JS Neergaardd, J Odgaard-Jensend, JJT Zawd, H Trane, GG Fabbronf
a Indiana Hemophilia & Thrombosis Center, Indianapolis, United States
b Department of Haematology, Christian Medical College, Vellore, India
c Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy
d Novo Nordisk A/S, Søborg, Denmark
e Haemophilia Treatment Centre, The Alfred Hospital, Melbourne, Australia
f Novo Nordisk Brasil, São Paulo, Brazil
Read
242
Timeswas read the article
132
Total PDF
110
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 17 | 23 | 40 |
| 2024 April | 29 | 13 | 42 |
| 2024 March | 22 | 17 | 39 |
| 2024 February | 13 | 20 | 33 |
| 2024 January | 6 | 8 | 14 |
| 2023 December | 11 | 23 | 34 |
| 2023 November | 10 | 19 | 29 |
| 2023 October | 2 | 9 | 11 |
